Skip to content

The Effects of Inorganic Nitrate on Cardiac Muscle in Angina

The Effects of Inorganic Nitrate on Cardiac Muscle: Physiology, Pharmacology and Therapeutic Potential in Patients Suffering From Angina

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02078921
Enrollment
70
Registered
2014-03-05
Start date
2012-10-31
Completion date
2014-12-31
Last updated
2015-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Stable Angina

Brief summary

Previous studies have shown that interventions which modestly increase blood nitrite\_ improve skeletal muscle function on exercise while sparing oxygen, and have been also shown to open up the blood flow during periods of oxygen deprivation. Inorganic nitrate in the diet is absorbed into the bloodstream, concentrated and reduced by bacteria in the mouth to nitrite, which is then absorbed into the bloodstream. . The purpose of this study is to look at the effects of oral inorganic nitrate supplementation on clinical markers of heart ischaemia and the frequency of angina.

Interventions

DRUGPlacebo

Sponsors

University of Aberdeen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 18 and over with chronic stable angina (≥2 months duration). Inclusion Criteria Following screening visit: * A positive exercise ECG (1mmSTD at J+0.08 seconds) on a modified Bruce protocol treadmill exercise test. * A positive dobutamine stress echocardiogram, * and/or a positive myocardial perfusion scan (MPI), * and/or a positive coronary angiogram.

Exclusion criteria

* Unable to do exercise test * Women of child bearing potential * If of a racial origin at risk of glucose-6-phosphate dehydrogenase (G6PD) deficiency, G6PD will be excluded prior to inclusion in the study * Resting STD\>=1mm * NYHA 3 or 4 HF or LVEF\<45% * Myocardial infarction or revascularisation within the last two months * Left bundle branch block (LBBB)

Design outcomes

Primary

MeasureTime frameDescription
Time to 1mm ST depression12 weeksThe primary outcome is to assess whether oral nitrate treatment increase the time to 1mm ST depression on a modified Bruce protocol exercise test

Secondary

MeasureTime frameDescription
Change in TDI systolic peak velocity12 weeksChange in Tissue Doppler Imaging (TDI) systolic peak velocity in ischaemic wall segments
Angina frequency12 weeksAngina frequency
GTN use frequency12 weeksGTN use frequency
Onset of chest pain12 weeksTime to onset of chest pain on a modified Bruce protocol exercise test
Nitrate/Nitrite12 weeksMeasurements of Nitrate and Nitrite in plasma
Metabolic, inflammatory and angiogenic plasma markers12 weeksMeasurements of metabolic, inflammatory and angiogenic markers in plasma
Questionnaire Score12 weeksModified Seattle Angina Questionnaire Score

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026